Carlos Mautalen
Overview
Explore the profile of Carlos Mautalen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1794
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Poole K, Treece G, Pearson R, Gee A, Bolognese M, Brown J, et al.
J Bone Miner Res
. 2021 Nov;
37(2):256-264.
PMID: 34738660
Romosozumab monoclonal antibody treatment works by binding sclerostin and causing rapid stimulation of bone formation while decreasing bone resorption. The location and local magnitude of vertebral bone accrual by romosozumab...
2.
Genant H, Engelke K, Bolognese M, Mautalen C, Brown J, Recknor C, et al.
J Bone Miner Res
. 2016 Aug;
32(1):181-187.
PMID: 27487526
Romosozumab, a monoclonal antibody that binds sclerostin, has a dual effect on bone by increasing bone formation and reducing bone resorption, and thus has favorable effects in both aspects of...
3.
Mautalen C, Schianchi A, Sigal D, Gianetti G, Vidan V, Bagur A, et al.
J Clin Densitom
. 2016 Mar;
19(4):471-476.
PMID: 26948141
The aim of the study was to report values for osteoporosis (OP) prevalence in Buenos Aires. Bone mineral density (BMD) at different skeletal sites was measured from November 2012 to...
4.
Mastaglia S, Mautalen C
Clin Cases Miner Bone Metab
. 2016 Jan;
12(3):262-4.
PMID: 26811709
Ossifying fibroma (OF) of the long bones is a benign fibro-osseous lesion typically seen in the first decade of life. OF usually progresses until the age of 10 years, but...
5.
Mastaglia S, Solis F, Bagur A, Mautalen C, Oliveri B
J Clin Densitom
. 2012 Mar;
15(2):159-64.
PMID: 22402116
Body fat distribution is gender specific: men tend to accumulate adipose tissue in the android region, whereas women tend to do so in the gynoid region. The aim of the...
6.
Miller P, Ragi-Eis S, Mautalen C, Ramirez F, Jonkanski I
Bone
. 2011 Sep;
49(6):1317-22.
PMID: 21945737
The Designed for intravenous (IV) Ibandronate reNal safety Evaluation (DIVINE) study was a 1-year prospective, randomized, open label, multi-center study that evaluated the renal safety of quarterly (every 3 months)...
7.
Lyles K, Colon-Emeric C, Magaziner J, Adachi J, Pieper C, Mautalen C, et al.
N Engl J Med
. 2007 Sep;
357(18):1799-809.
PMID: 17878149
Background: Mortality is increased after a hip fracture, and strategies that improve outcomes are needed. Methods: In this randomized, double-blind, placebo-controlled trial, 1065 patients were assigned to receive yearly intravenous...
8.
Black D, Delmas P, Eastell R, Reid I, Boonen S, Cauley J, et al.
N Engl J Med
. 2007 May;
356(18):1809-22.
PMID: 17476007
Background: A single infusion of intravenous zoledronic acid decreases bone turnover and improves bone density at 12 months in postmenopausal women with osteoporosis. We assessed the effects of annual infusions...
9.
Lindsay R, Scheele W, Neer R, Pohl G, Adami S, Mautalen C, et al.
Arch Intern Med
. 2004 Oct;
164(18):2024-30.
PMID: 15477438
Background: Teriparatide (recombinant human parathyroid hormone [1-34]) reduces fracture risk in postmenopausal women with osteoporosis. We assessed the safety and incidence of new vertebral fractures after withdrawal of teriparatide. Methods:...
10.
Tau C, Mautalen C, Casco C, Alvarez V, Rubinstein M
Bone
. 2004 Jun;
35(1):210-6.
PMID: 15207759
Chronic idiopathic hyperphosphatasia (CIH), or juvenile Paget disease, is a rare disorder characterized by increased bone turnover and progressive enlargement of bones. We report a girl, 6 1/2 years old,...